Ultragenyx Pharmaceutical
RARE
RARE
164 hedge funds and large institutions have $2.76B invested in Ultragenyx Pharmaceutical in 2017 Q1 according to their latest regulatory filings, with 22 funds opening new positions, 66 increasing their positions, 59 reducing their positions, and 25 closing their positions.
New
Increased
Maintained
Reduced
Closed
more funds holding in top 10
Funds holding in top 10: →
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less call options, than puts
Call options by funds: $ | Put options by funds: $
less ownership
Funds ownership: →
6% less capital invested
Capital invested by funds: $2.93B → $2.76B (-$167M)
6% less funds holding
Funds holding: 174 → 164 (-10)
12% less first-time investments, than exits
New positions opened: 22 | Existing positions closed: 25
Holders
164
Holding in Top 10
2
Calls
$9.32M
Puts
$10.2M
Top Buyers
| 1 | +$214M | |
| 2 | +$79.7M | |
| 3 | +$15.4M | |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
+$11M |
| 5 |
FAM
Fred Alger Management
New York
|
+$10.6M |
Top Sellers
| 1 | -$45.7M | |
| 2 | -$33.1M | |
| 3 | -$23.7M | |
| 4 |
EMFAT
Emerald Mutual Fund Advisers Trust
Leola,
Pennsylvania
|
-$18.6M |
| 5 |
PC
Polar Capital
London,
United Kingdom
|
-$14.7M |